Pfizer Free Cash Flow 2010-2024 | PFE

Pfizer free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Pfizer annual free cash flow for 2023 was $4.793B, a 81.59% decline from 2022.
  • Pfizer annual free cash flow for 2022 was $26.031B, a 12.85% decline from 2021.
  • Pfizer annual free cash flow for 2021 was $29.869B, a 145.29% increase from 2020.

Pfizer Free Cash Flow 2010-2024 | PFE

  • Pfizer annual free cash flow for 2023 was $4.793B, a 81.59% decline from 2022.
  • Pfizer annual free cash flow for 2022 was $26.031B, a 12.85% decline from 2021.
  • Pfizer annual free cash flow for 2021 was $29.869B, a 145.29% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$763.3B
Novo Nordisk (NVO)$377.1B
Johnson & Johnson (JNJ)$363.9B
AbbVie (ABBV)$309.7B
Merck (MRK)$248.6B
Roche Holding AG (RHHBY)$247.8B
AstraZeneca (AZN)$217.9B
Novartis AG (NVS)$210.4B
Sanofi (SNY)$132.3B
Bayer (BAYRY)$22.2B
Innoviva (INVA)$1.2B